Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Shares Issued (2016 - 2025)

Enanta Pharmaceuticals' Shares Issued history spans 14 years, with the latest figure at $141000.0 for Q4 2025.

  • For Q4 2025, Shares Issued changed N/A year-over-year to $141000.0; the TTM value through Dec 2025 reached $286000.0, up 94.56%, while the annual FY2025 figure was $145000.0, 1.36% down from the prior year.
  • Shares Issued reached $141000.0 in Q4 2025 per ENTA's latest filing, up from $51000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $10.4 million in Q4 2021 to a low of $28000.0 in Q2 2024.
  • Average Shares Issued over 5 years is $1.7 million, with a median of $784000.0 recorded in 2021.
  • Peak YoY movement for Shares Issued: skyrocketed 1149.58% in 2021, then plummeted 95.15% in 2023.
  • A 5-year view of Shares Issued shows it stood at $10.4 million in 2021, then crashed by 89.18% to $1.1 million in 2022, then crashed by 82.24% to $200000.0 in 2023, then tumbled by 66.0% to $68000.0 in 2024, then surged by 107.35% to $141000.0 in 2025.
  • Per Business Quant, the three most recent readings for ENTA's Shares Issued are $141000.0 (Q4 2025), $51000.0 (Q3 2025), and $94000.0 (Q1 2025).